UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000045819
Receipt number R000052310
Scientific Title Biological Psychiatry Study in Depressive Symptoms Associated with Heart Failure
Date of disclosure of the study information 2022/05/01
Last modified on 2023/04/24 15:46:12

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Biological Psychiatry Study in Depressive Symptoms Associated with Heart Failure

Acronym

Biological Psychiatry Study in Depressive Symptoms Associated with Heart Failure

Scientific Title

Biological Psychiatry Study in Depressive Symptoms Associated with Heart Failure

Scientific Title:Acronym

Biological Psychiatry Study in Depressive Symptoms Associated with Heart Failure

Region

Japan


Condition

Condition

Depression, Heart Failure

Classification by specialty

Cardiology Psychiatry Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

1) To evaluate the involvement of abnormalities in the kynurenic pathway in clinical practice and to elucidate the biological basis of pathology-specific depression in heart failure.
2) To evaluate the applicability of existing predictive markers to heart failure patients in order to establish a highly accurate method for early detection of depression.

Basic objectives2

Others

Basic objectives -Others

Identification of biomarkers

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Correlation between PHQ-9 scores and blood levels of various substances (tryptophan, kynurenine, kynurenic acid, quinolinic acid) and various (CIDEC, RNASE1, SLC36A1, STYXL1) mRNA expression levels

Key secondary outcomes

1) Correlation between PHQ-9 score and severity of heart failure
2) Correlation between PHQ-9 score and duration of heart failure


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1) Those who are 20 years of age or older at the time of obtaining consent
2) A person who, after receiving sufficient explanation and understanding, has given written consent of his or her own free will to participate in this research

Key exclusion criteria

1) Patients with serious (systemic or local) infections
2) Patients who are considered to be easily infected due to serious underlying diseases or reduced immunocompetence
3) Patients with severe cognitive impairment
4) Other patients who are judged by the principal investigator to be inappropriate as research subjects

Target sample size

26


Research contact person

Name of lead principal investigator

1st name Ichiro
Middle name
Last name Kusumi

Organization

Hokkaido University

Division name

Department of psychiatry, graduate school of medical science

Zip code

060-8648

Address

Kita 14-jo Nishi 5, Kita-ku, Sapporo City, Hokkaido

TEL

011-706-5160

Email

ikusumi@med.hokudai.ac.jp


Public contact

Name of contact person

1st name Tomoyuki
Middle name
Last name Isoyama

Organization

Hokkaido University

Division name

Department of psychiatry, graduate school of medical science

Zip code

060-8648

Address

Kita 14-jo Nishi 5, Kita-ku, Sapporo City, Hokkaido

TEL

011-706-5160

Homepage URL


Email

tgo82301@elms.hokudai.ac.jp


Sponsor or person

Institute

Hokkaido University

Institute

Department

Personal name



Funding Source

Organization

none

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Ethical Review Board for Life Science and Medical Research, Hokkaido University Hospital

Address

Kita 14-jo Nishi 5, Kita-ku, Sapporo City, Hokkaido

Tel

011-706-7636

Email

crjimu@huhp.hokudai.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

北海道大学病院(北海道)


Other administrative information

Date of disclosure of the study information

2022 Year 05 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2021 Year 09 Month 29 Day

Date of IRB

2021 Year 09 Month 29 Day

Anticipated trial start date

2021 Year 11 Month 01 Day

Last follow-up date

2023 Year 09 Month 30 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

The following items will be surveyed, and the data will be used for this study.
1) Basic information of the study subjects: age, sex, duration of illness, severity
of heart failure (New York Heart Association (NYHA) classification)
2) Assessment of depression using a self-administered questionnaire(one time): PHQ-9 (Patient Health Questionnaire-9)
3) Blood biochemical tests(one time): tryptophan, kynurenine, kynurenic acid, quinolinic acid, mRNA(CIDEC, RNASE1, SLC36A1, STYXL1)


Management information

Registered date

2021 Year 10 Month 21 Day

Last modified on

2023 Year 04 Month 24 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000052310